St. Jude bird flu vaccine test successful

May 02, 2006

U.S. scientists say a commercially developed vaccine has successfully protected mice and ferrets against a highly lethal avian influenza virus.

The research, conducted at St. Jude Children's Research Hospital in Memphis, Tenn., involved a vaccine developed by Vical Inc. of San Diego, Calif.

Richard Webby, an assistant faculty member in St. Jude's infectious diseases department, said the finding, coupled with results of previous studies, suggests such a vaccine would protect humans against multiple variants of the bird and human influenza viruses, including the H5N1 virus that might mutate so it can spread readily from person to person.

Flu experts and public health officials fear such an H5N1 variant would trigger a human pandemic.

Webby was to present the study Wednesday in Denver, Colo., during a U.S. Public Health Service Professional Conference.

Copyright 2006 by United Press International

Explore further: Africans in New York complain of Ebola stigma

add to favorites email to friend print save as pdf

Related Stories

Researchers use microRNA to trap mutant viruses in the lab

Aug 12, 2013

(Phys.org) —It's a scenario straight out of a sci-fi horror flick. Scientists take a deadly virus that people can only catch from birds and genetically engineer it so we can give it to each other. Unfortunately, ...

Panel backs sharing studies of lab-made bird flu

Mar 30, 2012

(AP) -- The U.S. government's biosecurity advisers said Friday they support publishing research studies showing how scientists made new easy-to-spread forms of bird flu because the studies, now revised, don't reveal details ...

Controversial 'bird flu' edits move ahead

Dec 22, 2011

Top US scientists on Wednesday defended their bid to stop details of a mutant bird flu virus from being published and called for global cooperation to ward off an uncontrollable pandemic.

Recommended for you

Cochrane Review of RDT for diagnosis of drug resistant TB

58 minutes ago

Researchers from the Cochrane Infectious Diseases Group, hosted at LSTM, have conducted an independent review to examine the diagnostic accuracy of the GenoType MTBDRsl assay for the detection of resistance ...

Model explains why HIV prevention dosing differs by sex

1 hour ago

A mathematical model developed by NIH grantees predicts that women must take the antiretroviral medication Truvada daily to prevent HIV infection via vaginal sex, whereas just two doses per week can protect men from HIV infection ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.